ZUG, SWITZERLAND AND VILNIUS, LITHUANIA / ACCESS Newswire / March 4, 2025 / Micreos Pharmaceuticals AG ("Micreos"), a preclinical-stage ...

Northway Biotech Enters Manufacturing Agreement With Kaida BioPharma for Lead Oncology Program KAD101 ACCESS Newswire. Updated May 21, 2025 5:23 AM.

In a sign of the importance of some of the imports and the damaging effect disruption could have on China's healthcare ...

Amgen to Expand Ohio Biotech Manufacturing Plant. More. Reuters. FILE PHOTO: An Amgen sign is seen at the company's headquarters in Thousand Oaks, California, U.S., November 6, 2019.

Debut is dipping its toes into the contract manufacturing business, with the goal of bringing biotech ingredients to the masses. After witnessing an increase in demand, especially among midsize ...

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

Genentech, a biotechnology company based in South San Francisco, could add 400 jobs in the Wake County town of Holly Springs after agreeing to an incentives deal with North Carolina. Why it ...

Leveraging Northway Biotech's 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for hormone-driven ovarian cancer WALTHAM, MASSACHUSETTS / ACCESS Newswire / May ...

Northway Biotech Enters Manufacturing Agreement With Kaida BioPharma for Lead Oncology Program KAD101 ACCESS Newswire. Updated May 21, 2025 8:23 AM.

Northway Biotech Enters Manufacturing Agreement With Kaida BioPharma for Lead Oncology Program KAD101 ACCESS Newswire. Updated May 21, 2025 8:23 AM.

Northway Biotech Enters Manufacturing Agreement With Kaida BioPharma for Lead Oncology Program KAD101 ACCESS Newswire. Updated May 21, 2025 8:23 AM.